Investor Presentaiton
Novo Nordisk Annual Report 2023
Introducing Novo Nordisk
Strategic Aspirations
Risks
Management
Consolidated statements
Additional information
95
Statement by the Board of Directors and Executive Management
The Board of Directors and Executive Management have today considered
and approved the Annual Report for Novo Nordisk A/S for the financial
year 1 January 2023 - 31 December 2023.
The consolidated financial statements are presented in accordance with
IFRS Accounting Standards as endorsed by the EU. The parent financial
statements are presented in accordance with the Danish Financial
Statements Act. Furthermore, the Annual Report is prepared in
accordance with disclosure requirements for listed companies.
In our opinion, the consolidated financial statements and the parent
financial statements give a true and fair view of the Group's and the
parent company's financial position at 31 December 2023, as well as
of the results of their operations and cash flows for the financial year
1 January 2023 - 31 December 2023.
In our opinion, the Management review contains a fair review of the
development of the Group's and the parent company's business and
financial matters, the results for the year and of the parent company's
financial position and the financial position as a whole of the entities
included in the consolidated financial statements, together with a
description of the principal risks and uncertainties that the Group
and the parent company face.
In our opinion, the Annual Report of Novo Nordisk A/S for the financial
year 1 January 2023 to 31 December 2023 identified as NOVO-2023-12-
31-en.zip is prepared, in all material respects, in compliance with the
ESEF Regulation.
The consolidated ESG statement for 1 January - 31 December 2023 has
been prepared in accordance with the Danish Financial Statements Act,
the Greenhouse Gas (GHG) Protocol and the reporting principles of
materiality, inclusivity, responsiveness and environmental, social and
governance accounting policies. In our opinion, the consolidated ESG
statement gives a true and fair account and a balanced and reasonable
presentation of the organisation's environmental, social and governance
performance in accordance with these principles.
We recommend the Annual Report for adoption at the Annual General
Meeting.
Bagsværd, 31 January 2024
Registered Executive Management
Board of Directors
Lars Fruergaard Jørgensen
President and CEO
Karsten Munk Knudsen
CFO
Helge Lund
Chair
Henrik Poulsen
Vice Chair
Elisabeth Dahl Christensen
Laurence Debroux
Andreas Fibig
Sylvie Grégoire
Liselotte Hyveled
Mette Bøjer Jensen
Kasim Kutay
Christina Law
Martin Mackay
Thomas RantzauView entire presentation